Mar 23, 2022
In this week’s View, Dr. Eagle discusses a comparison of patients infected with Delta versus Omicron COVID-19 variants, then looks at a post-hoc analysis of the EMPEROR-Preserved trial on mineralocorticoid receptor antagonists and empagliflozin in patients with heart failure and preserved ejection fraction. Finally, Dr. Eagle explores a recent NCDR Registry paper on sex differences in management and outcomes of acute myocardial infarction patients presenting with cardiogenic shock.